New Strategies for Cardiovascular Disease Management
In our attempts to increase medical awareness on new strategies for screening and monitoring of Cardiovascular Disease (CVD) risks, Omron recently sponsored a satellite symposium in Orlando, Florida in the US. The title of the symposium "Blood Pressure & Augmentation Index Monitoring" clearly shows that Omron is focusing on new and improved ways of assessing diseases directly related to CVD.
Dr. Thomas G. Pickering led the symposium and all Speakers were leading physicians and researchers in this area from the United States, Europe and Japan.
The report of the symposium includes interesting articles on the role of home blood pressure monitoring and the role augmentation index monitoring could have in the future in CVD management.
"Studies evaluating blood pressure as a prognostic factor for cardiovascular (CV) disease usually focus on the levels of diastolic blood pressure (DBP) or
systolic blood pressure (SBP). However, blood pressure may be divided into two components: a steady component(mean blood pressure) and a pulsatile omponent, "pulse
pressure (PP)." Mean blood pressure is the product of
vascular resistance and cardiac output; PP, the difference
between SBP and DBP, is influenced by ventricular ejection, arterial stiffness, and wave reflections."
(fragment taken out Symposium report, download available below)
